Shopping Cart
- Remove All
- Your shopping cart is currently empty
Oxiracetam (ISF2522), a cyclic derivative of gamma-aminobutyric acid (GABA), is utilized for the treatment of cognitive impairments.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $50 | In Stock | |
10 mg | $76 | In Stock | |
25 mg | $118 | In Stock | |
50 mg | $148 | In Stock | |
100 mg | $232 | In Stock | |
200 mg | $349 | In Stock | |
1 mL x 10 mM (in DMSO) | $65 | In Stock |
Description | Oxiracetam (ISF2522), a cyclic derivative of gamma-aminobutyric acid (GABA), is utilized for the treatment of cognitive impairments. |
In vitro | In BALB/c mice, Oxiracetam (50 mg/kg i.p.) has been shown to improve avoidance acquisition. Similarly, in rats, pretreatment with Oxiracetam (30 mg/kg) has demonstrated efficacy in ameliorating cognitive deficits induced by trimethyltin. |
Alias | ISF2522 |
Molecular Weight | 158.16 |
Formula | C6H10N2O3 |
Cas No. | 62613-82-5 |
Smiles | C(C(N)=O)N1CC(O)CC1=O |
Relative Density. | 1.416 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 10 mg/mL (63.23 mM) | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.